Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership402 shares
Latest Disclosed Value $ 11,943
Walleye Capital LLC ownership in TVTX / Travere Therapeutics, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 402 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $11,943 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,454 shares of Travere Therapeutics, Inc.. This represents a change in shares of -92.63% during the quarter. The current value of the position is $18,170 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options. The firm currently holds call options representing 4,100 of underlying shares valued at $121,811 USD and put options representing 3,500 of underlying shares valued at $103,985 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 402 -5,052 -92.63 12 -94.71 0.0000
2026-05-08 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 402 -5,052 12 0.0000
2026-02-13 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 5,454 -59,687 -91.63 208 -86.63 0.0006
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 65,141 -126,726 -66.05 1,557 -45.19 0.0058
2025-08-13 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 191,867 -77,271 -28.71 2,840 -41.12 0.0110
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 269,138 -158,092 -37.00 4,823 -35.21 0.0218
2025-02-13 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 427,230 -61,223 -12.53 7,442 8.91 0.0182
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 488,453 221,982 83.30 6,833 212.01 0.0142
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 266,471 254,096 2,053.30 2,190 2,205.26 0.0039
2024-05-15 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 12,375 12,375 95 0.0002
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -32,899 -100.00 0 -100.00
2023-11-21 2023-09-30 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 32,899 -700,963 -95.52 294 -97.39 0.0008
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 32,899 -700,963 294 0.0008
2023-08-14 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 733,862 692,631 1,679.88 11,272 1,115.97 0.0408
2023-05-15 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 41,231 -465,852 -91.87 927 -91.31 0.0139
2023-02-14 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 507,083 168,659 49.84 10,664 27.87 0.1945
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 338,424 130,529 62.79 8,339 65.55 0.1591
2022-08-19 2022-06-30 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 207,895 41,375 24.85 5,037 17.39 0.1388
2022-08-08 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 207,895 41,375 5,037 0.1388
2022-05-27 2022-03-31 13F/A-01 TRAVERE THERAPEUTICS COM 89422G107 166,520 123,425 286.40 4,291 220.70 0.1147
2022-05-16 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 166,520 123,425 4,291 0.0874
2022-05-27 2021-12-31 13F/A-01 TRAVERE THERAPEUTICS COM 89422G107 43,095 43,095 1,338 0.0416
2022-03-03 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 43,095 43,095 1,338 0.0334
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -22,778 -100.00 0 -100.00
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 22,778 13,931 157.47 332 50.23 0.0113
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 8,847 8,847 221 0.0128
2020-05-15 2020-03-31 13F RETROPHIN COM 761299106 0 -18,996 -100.00 0 -100.00
2020-02-14 2019-12-31 13F RETROPHIN COM 761299106 18,996 -58,681 -75.54 269 -70.11 0.0175
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 77,677 77,677 900 0.0536
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A TRAVERE THERAPEUTICS COM Call 4,100 -66.39 122 -74.03 n/a n/a n/a
2026-05-08 2026-03-31 13F TRAVERE THERAPEUTICS COM Call 4,100 122 n/a n/a n/a
2026-02-13 2025-12-31 13F TRAVERE THERAPEUTICS COM Call 12,200 25.77 466 101.73 n/a n/a n/a
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM Call 9,700 246.43 232 463.41 n/a n/a n/a
2025-08-13 2025-06-30 13F TRAVERE THERAPEUTICS COM Call 2,800 41 n/a n/a n/a
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM Call 20,700 170 n/a n/a n/a
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TRAVERE THERAPEUTICS COM Call 100 1 n/a n/a n/a
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM Call 100 1 n/a n/a n/a
2020-05-15 2020-03-31 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F RETROPHIN COM Call 2,000 -87.88 28 -85.34 n/a n/a n/a
2019-11-14 2019-09-30 13F RETROPHIN COM Call 16,500 191 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A TRAVERE THERAPEUTICS COM Put 3,500 -47.76 104 -59.77 n/a n/a n/a
2026-05-08 2026-03-31 13F TRAVERE THERAPEUTICS COM Put 3,500 104 n/a n/a n/a
2026-02-13 2025-12-31 13F TRAVERE THERAPEUTICS COM Put 6,700 -22.99 256 23.67 n/a n/a n/a
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM Put 8,700 208 n/a n/a n/a
2024-08-14 2024-06-30 13F TRAVERE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F TRAVERE THERAPEUTICS COM Put 1,400 11 n/a n/a n/a
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-21 2023-09-30 13F/A TRAVERE THERAPEUTICS COM Put 2,700 24 n/a n/a n/a
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM Put 2,700 24 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.